AIM ImmunoTech Inc.·4

Jun 13, 11:04 AM ET

Equels Thomas K 4

4 · AIM ImmunoTech Inc. · Filed Jun 13, 2025

Insider Transaction Report

Form 4
Period: 2025-06-12
Equels Thomas K
DirectorCEO & President
Transactions
  • Purchase

    Common Stock

    2025-06-12$8.70/sh+103$89638,675 total

Documents

1 file
  • 4
    ownership.xmlPrimary